Search Results - "Ateşoğlu, Elif Birtaş"

Comparative Efficacy and Safety of Beam and Team Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients by Deveci, Burak, Ateşoğlu, Elif Birtaş, Bayrak, Esra, Kublashvili, George, Toptaş, Tayfur, Saba, Rabin, Gülbaş, Zafer

“…Conditioning regimens with high-dose chemotherapy and autologous stem cell transplantation (ASCT) are the mainstays of treatment in lymphoma patients. Although…”
Get full text

A survey evaluating hematology physicians’ perspectives on central nervous system prophylaxis by Demirci, Ufuk, Yüksel, Meltem Kurt, Kırkızlar, Hakkı Onur, Ateşoğlu, Elif Birtaş, Mehtap, Özgür, Salim, Ozan, Demir, Ahmet Muzaffer, Akay, Olga Meltem

“…Central nervous system (CNS) prophylactic options for diffuse large B-cell lymphoma (DLBCL) are administered differently in most centers. Unfortunately, there…”
Get full text

P1073: A NEW SCORING SYSTEM TO PREDICT SURVIVAL IN ELDERLY ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: STUDY BY TURKISH SOCIETY OF HAEMATOLOGY LYMPHOMA ACADEMY WORKING GROUP by Mehtap, Özgür, Toptas, Tayfur, Sinan Dal, Mehmet, Hayri Özsan, Güner, Sayinalp, Nigün, Saydam, Güray, Ali Uçar, Mehmet, Onur Kirgizlar, Hakki, Salim, Ozan, Tekinalp, Atakan, Özkalemkaş, Fahir, Pepedil Tanrikulu, Funda, Meltem Akay, Olga, Kiliçaslan, Emrah, Paydas, Semra, Civriz, Sinem, Yilmaz, Mehmet, Karakuş, Volkan, Geçgel, Fatma, Darçin, Tahir, Erdoğan, Elçin, Çinar, Erkin, Keklik Karadağ, Fatma, Ataş, Ünal, Gürsoy, Vildan, Sertaç Durusoy, Salih, Birtaş Ateşoğlu, Elif, Tombak, Anil, Büyükkurt, Nurhilal, Özcan, Muhit, Altuntaş, Fevzi, Burhan Ferhanoğlu, Ahmet

Get full text

Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2) by Atalay, Figen, Ateşoğlu, Elif Birtaş

“…Only one-third of elderly (>60 years) AML and MDS-RAEB2 patients may receive intensive chemotherapy treatment alternatives that are limited in this patient…”
Get full text

Relationship of P-Selectin Glycoprotein Ligand-1 to Prognosis in Patients With Multiple Myeloma by Atalay, Figen, Ateşoğlu, Elif Birtaş, Yıldız, Semsi, Firatlı-Tuglular, Tülin, Karakuş, Sema, Bayık, Mahmut

“…Micro-Abstract The aim of the present study was to investigate the relationship between PSGL-1 expression in the bone marrow and the known prognostic factors…”
Get full text

Blastic Plasmacytoid Dendritic Cell Neoplasm: Skin and Bone Marrow Infiltration of Three Cases and the Review of the Literature by Atalay, Figen, Demirci, Gülşen Tükenmez, Bayramgürler, Dilek, Ateşoğlu, Elif Birtaş, Yıldız, Semsi

“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a distinct and rare neoplastic entity and was classified as a subgroup of acute myeloblastic leukemia…”
Get full text

Are cup-like blasts specific to AML patients with FLT3 ITD and a normal karyotype? An ALL case report and review of the literature by Mehtap, Özgür, Birtaş Ateşoğlu, Elif, Gönüllü, Emel, Keski, Hakan, Hacıhanefioğlu, Abdullah

“…Cup-like morphology is defined as cup-like nuclear invagination spanning ≥25% of the nuclear diameter in >10% of blasts. Studies have shown that FLT3 ITD and…”
Get full text

The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera by Mehtap, Ozgür, Ateşoğlu, Elif Birtaş, Tarkun, Pınar, Gönüllü, Emel, Keski, Hakan, Topçu, Yıldıray, Uzülmez, Nilüfer, Sünnetçi, Deniz, Hacıhanefioğlu, Abdullah

“…Vascular events are a common complication in patients with polycythemia vera (PV) and essential thrombocythemia (ET). This study aimed to analyze the…”
Get full text

Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients by Terzi Demirsoy, Esra, Mehtap, Ozgür, Birtas Atesoglu, Elif, Tarkun, Pinar, Gedük, Ayfer, Eren, Necmi, Hacihanefioglu, Abdullah

“…Multiple myeloma is the plasma cell malignancy in which bone involvement is common. The Fibroblast growth factor-23 (FGF-23)/Klotho pathway plays a major role…”
Get full text

Prognostic importance of thrombospondin-1, VEGF, PDGFR- β in diffuse large B-cell lymphoma by BATMAN, Adnan, CİFTCİLER, Rafiye, ATEŞOĞLU, Elif Birtaş, HACIHANEFİOĞLU, Abdullah

“…Aim: In this study, we aimed to investigate the relationship between the staining rates of thrombospondin-1, VEGF, and PDGFR-in tissue preparations in patients…”
Get full text

Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients by Tarkun, Pinar, Birtas Atesoglu, Elif, Mehtap, Ozgur, Musul, Mahmut Mert, Hacihanefioglu, Abdullah

“…Multiple myeloma (MM) is a hematological cancer associated with increased clonal malignant plasma cells. Growth differentiation factor 15 (GDF 15) is a protein…”
Get more information

A case of Cauda Equina syndrome in a leukemic patient due to intrathecal methotrexate by Birtaş Ateşoğlu, Elif, Fıratlı Tuğlular, Tülin, Adıgüzel, Cafer, Kaygusuz, Işık, Noyan, Figen, Çetiner, Mustafa, Bayık, Mahmut

“…The leukemias may cause neurologic dysfunction through either direct invasion of the nervous system or indirectly through cytopenias, or it may occur as a…”
Get full text

Late-onset Anticonvulsant Hypersensitivity Syndrome Mimicking Lymphoma by Geduk, Ayfer, Atesoglu, Elif Birtas, Mehtap, Ozgur, Demirsoy, Esra Terzi, Can, Burak, Tarkun, Pinar, Hacihanefioglu, Abdullah

“…Anticonvulsant hypersensitivity syndrome is a fatal, idiosyncratic drug reaction that is caused by aromatic antiepileptic drugs. This cutaneous drug reaction…”
Get full text

The Effect of PET/CT Deauville Criteria on Progression Free Survival and Overall Survival in Multiple Myeloma Patients Following Autologous Stem Cell Transplantation by Tuglular, Tulin, Şahin, Eren, Öneş, Tunç, atalay, figen, Ateşoğlu, Elif Birtaş, Mengüç, Meral Uluköylü, Atagündüz, Işık Kaygusuz, Toptas, Tayfur

Get full text

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data by Birtas Atesoglu, Elif, Gulbas, Zafer, Uzay, Ant, Ozcan, Muhit, Ozkalemkas, Fahir, Dal, Mehmet Sinan, Kalyon, Hakan, Akay, Olga Meltem, Deveci, Burak, Bekoz, Huseyin, Sevindik, Omur Gokmen, Toptas, Tayfur, Yilmaz, Fergun, Koyun, Derya, Alkis, Nihan, Alacacioglu, Inci, Sonmez, Mehmet, Yavasoglu, Irfan, Tombak, Anil, Mehtap, Ozgur, Kurnaz, Fatih, Yuce, Orhan Kemal, Karakus, Volkan, Turgut, Mehmet, Kurekci, Derya Deniz, Ayer, Mesut, Keklik, Muzaffer, Buyuktas, Deram, Ozbalak, Murat, Ferhanoglu, Burhan

“…Glofitamab is a CD3xCD20 bi-specific antibody with two fragments directed to the CD20 antigen and a single CD3-binding fragment. Encouraging response and…”
Get full text

A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients by Mehtap, Özgür, Toptas, Tayfur, Dal, Mehmet S, Karadag, Fatma Keklik, Atas, Unal, Özsan, Güner H, Sayınalp, Nilgün, Saydam, Guray, Uçar, Mehmet Ali, Kırkızlar, Hakkı Onur, Salim, Ozan, Tekinalp, Atakan, Özkalemkaş, Fahir, Pepedi, Funda, Akay, Olga M, Kılıçaslan, Emrah, Paydas, Semra, Bozdağ, Sinem Civriz, Yılmaz, Mehmet, Karakus, Volkan, Arikan, Fatma Gecgel, Darçın, Tahir, Erdogan, Elcin, Cinar, Erkin, Gürsoy, Vildan, Durusoy, Salih S, Birtaş Ateşoğlu, Elif, Tombak, Anıl, Büyükkurt, Nurhilal, Özcan, Muhit, Altuntaş, Fevzi, Kaygusuz Atagündüz, Işık, Ferhanoglu, Burhan

“…Predictive prognostic scoring (PS) systems are not primarily applicable to elderly patients with classical Hodgkin lymphoma (cHL). The objective of this study…”
Get full text

The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma by Uluköylü Mengüç, Meral, Mehtap, Özgür, Dağlıöz Görür, Gözde, Birtaş Ateşoğlu, Elif, Gedük, Ayfer, Ünal, Serkan, Tarkun, Pınar, Hacıhanefioğlu, Abdullah

“…Diffuse large B cell lymphoma is the most frequent aggressive non-Hodgkin lymphoma. Predicting response and estimating prognosis earlier makes management of…”
Get full text

Carfilzomib-induced tumor lysis syndrome in relapsed multiple myeloma: a report of two cases by Terzi Demirsoy, Esra, Birtas Atesoglu, Elif, Eren, Necmi, Gedük, Ayfer, Mehtap, Ozgur, Tarkun, Pınar, Hacıhanefioğlu, Abdullah

“…Background: Tumor lysis syndrome (TLS) is a potentially fatal complication of cancer therapy characterized by severe electrolyte and metabolic abnormalities…”
Get full text

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis by Birtas Atesoglu, Elif, Tarkun, Pinar, Demirsoy, Esra Terzi, Geduk, Ayfer, Mehtap, Ozgur, Batman, Adnan, Kaya, Fatih, Cekmen, Mustafa Baki, Gulbas, Zafer, Hacıhanefioglu, Abdullah

“…Immune thrombocytopenia (ITP) is an autoimmune disease characterized by dysregulation of T cells. Programmed death (PD) 1 and programmed death 1 ligand 1…”
Get more information

Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study by Akay, Olga Meltem, Ozbalak, Murat, Pehlivan, Mustafa, Yildiz, Birol, Uzay, Ant, Yigenoglu, Tugce Nur, Elverdi, Tugrul, Kaynar, Leylagul, Ayyildiz, Orhan, Yonal Hindilerden, Ipek, Goksoy, Hasan Sami, Izmir Guner, Sebnem, Gunes, Ahmet Kursad, Sonmez, Mehmet, Kurt Yuksel, Meltem, Civriz Bozdag, Sinem, Ozkurt, Zubeyde Nur, Toptas, Tayfur, Dogu, Mehmet Hilmi, Salim, Ozan, Saydam, Guray, Yavasoglu, Irfan, Ayli, Meltem, Ozet, Gulsum, Albayrak, Murat, Birtas Atesoglu, Elif, Toprak, Selami K., Yildirim, Rahsan, Mehtap, Ozgur, Kalayoglu Besisik, Sevgi, Nalcaci, Meliha, Altuntas, Fevzi, Ferhanoglu, Burhan

“…The AETHERA trial reported an increased progression‐free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high‐risk Hodgkin…”
Get full text